Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organiz...
Gespeichert in:
| Veröffentlicht in: | Molecular syndromology 2021-07, Vol.12 (4), p.202-218 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 218 |
|---|---|
| container_issue | 4 |
| container_start_page | 202 |
| container_title | Molecular syndromology |
| container_volume | 12 |
| creator | Dierssen, Mara Herault, Yann Helguera, Pablo Martínez de Lagran, Maria Vazquez, Anna Christian, Bradley Carmona-Iragui, Maria Wiseman, Frances Mobley, William Fisher, Elizabeth M.C. Brault, Veronique Esbensen, Anna Jacola, Lisa M. Potier, Marie Claude Hamlett, Eric D. Abbeduto, Leonard del Hoyo Soriano, Laura Busciglio, Jorge Iulita, Maria Florencia Crispino, John Malinge, Sébastien Barone, Eugenio Perluigi, Marzia Costanzo, Floriana Delabar, Jean Maurice Bartesaghi, Renata Dekker, Alain D. De Deyn, Peter Fortea Ormaechea, Juan Shaw, Patricia A. Haydar, Tarik F. Sherman, Stephanie L. Strydom, André Bhattacharyya, Anita |
| description | Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and pharmacological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21. |
| doi_str_mv | 10.1159/000514437 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000514437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2563715763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-a0b388436ce1c2e062b8e9d8499b4e61770135b8877ee89fa8674c778c9e42993</originalsourceid><addsrcrecordid>eNptkc-PEyEUx4nRuJt1D96NIfHiHqowwAAeTNbqupvUmNh68EQY5k0HnUKFmd30v3dq6_gjHgiE9-HzePki9JiSF5QK_ZIQIijnTN5Dp7Qs6UxJKe9P51KfoPOcv44YYbpQlD5EJ4zzgnKtT1F8M_iu9mGN-xbw1dAPCfCqhWS3HjJuYsJv413Ay12oU9zAq31xXD7V-Cb0kILtfQy2w_MYGkgQHODY_LStCoo_QQabXIuX0Xnod4_Qg8Z2Gc6P-xn6fPVuNb-eLT6-v5lfLmaOC9XPLKmYUpyVDqgrgJRFpUDXavxzxaGkUhLKRKXGWQGUbqwqJXdSKqeBF1qzM_T64N0O1QZqB6FPtjPb5Dc27Uy03vxdCb4163hrFGNaEDEKLg6C9p9n15cLs78jjAktC35LR_b5sVmK3wfIvdn47KDrbIA4ZFOIkkkqZMl-a12KOSdoJjclZp-nmfIc2ad_zjCRv9IbgWcH4JtNa0gT8GH55aAw27oZqSf_pY5dfgAWya6f</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563715763</pqid></control><display><type>article</type><title>Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society</title><source>Karger Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Dierssen, Mara ; Herault, Yann ; Helguera, Pablo ; Martínez de Lagran, Maria ; Vazquez, Anna ; Christian, Bradley ; Carmona-Iragui, Maria ; Wiseman, Frances ; Mobley, William ; Fisher, Elizabeth M.C. ; Brault, Veronique ; Esbensen, Anna ; Jacola, Lisa M. ; Potier, Marie Claude ; Hamlett, Eric D. ; Abbeduto, Leonard ; del Hoyo Soriano, Laura ; Busciglio, Jorge ; Iulita, Maria Florencia ; Crispino, John ; Malinge, Sébastien ; Barone, Eugenio ; Perluigi, Marzia ; Costanzo, Floriana ; Delabar, Jean Maurice ; Bartesaghi, Renata ; Dekker, Alain D. ; De Deyn, Peter ; Fortea Ormaechea, Juan ; Shaw, Patricia A. ; Haydar, Tarik F. ; Sherman, Stephanie L. ; Strydom, André ; Bhattacharyya, Anita</creator><creatorcontrib>Dierssen, Mara ; Herault, Yann ; Helguera, Pablo ; Martínez de Lagran, Maria ; Vazquez, Anna ; Christian, Bradley ; Carmona-Iragui, Maria ; Wiseman, Frances ; Mobley, William ; Fisher, Elizabeth M.C. ; Brault, Veronique ; Esbensen, Anna ; Jacola, Lisa M. ; Potier, Marie Claude ; Hamlett, Eric D. ; Abbeduto, Leonard ; del Hoyo Soriano, Laura ; Busciglio, Jorge ; Iulita, Maria Florencia ; Crispino, John ; Malinge, Sébastien ; Barone, Eugenio ; Perluigi, Marzia ; Costanzo, Floriana ; Delabar, Jean Maurice ; Bartesaghi, Renata ; Dekker, Alain D. ; De Deyn, Peter ; Fortea Ormaechea, Juan ; Shaw, Patricia A. ; Haydar, Tarik F. ; Sherman, Stephanie L. ; Strydom, André ; Bhattacharyya, Anita</creatorcontrib><description>Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and pharmacological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.</description><identifier>ISSN: 1661-8769</identifier><identifier>EISSN: 1661-8777</identifier><identifier>DOI: 10.1159/000514437</identifier><identifier>PMID: 34421499</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Life Sciences ; Syndrome Conferences, Symposia or Workshops</subject><ispartof>Molecular syndromology, 2021-07, Vol.12 (4), p.202-218</ispartof><rights>2021 S. Karger AG, Basel</rights><rights>Copyright © 2021 by S. Karger AG, Basel.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2021 by S. Karger AG, Basel 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-a0b388436ce1c2e062b8e9d8499b4e61770135b8877ee89fa8674c778c9e42993</citedby><cites>FETCH-LOGICAL-c458t-a0b388436ce1c2e062b8e9d8499b4e61770135b8877ee89fa8674c778c9e42993</cites><orcidid>0000-0002-3360-4498 ; 0000-0003-3062-7384 ; 0000-0003-2462-7150 ; 0000-0002-0360-7145 ; 0000-0001-7049-6900</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339505/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339505/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,2423,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34421499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03359724$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dierssen, Mara</creatorcontrib><creatorcontrib>Herault, Yann</creatorcontrib><creatorcontrib>Helguera, Pablo</creatorcontrib><creatorcontrib>Martínez de Lagran, Maria</creatorcontrib><creatorcontrib>Vazquez, Anna</creatorcontrib><creatorcontrib>Christian, Bradley</creatorcontrib><creatorcontrib>Carmona-Iragui, Maria</creatorcontrib><creatorcontrib>Wiseman, Frances</creatorcontrib><creatorcontrib>Mobley, William</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C.</creatorcontrib><creatorcontrib>Brault, Veronique</creatorcontrib><creatorcontrib>Esbensen, Anna</creatorcontrib><creatorcontrib>Jacola, Lisa M.</creatorcontrib><creatorcontrib>Potier, Marie Claude</creatorcontrib><creatorcontrib>Hamlett, Eric D.</creatorcontrib><creatorcontrib>Abbeduto, Leonard</creatorcontrib><creatorcontrib>del Hoyo Soriano, Laura</creatorcontrib><creatorcontrib>Busciglio, Jorge</creatorcontrib><creatorcontrib>Iulita, Maria Florencia</creatorcontrib><creatorcontrib>Crispino, John</creatorcontrib><creatorcontrib>Malinge, Sébastien</creatorcontrib><creatorcontrib>Barone, Eugenio</creatorcontrib><creatorcontrib>Perluigi, Marzia</creatorcontrib><creatorcontrib>Costanzo, Floriana</creatorcontrib><creatorcontrib>Delabar, Jean Maurice</creatorcontrib><creatorcontrib>Bartesaghi, Renata</creatorcontrib><creatorcontrib>Dekker, Alain D.</creatorcontrib><creatorcontrib>De Deyn, Peter</creatorcontrib><creatorcontrib>Fortea Ormaechea, Juan</creatorcontrib><creatorcontrib>Shaw, Patricia A.</creatorcontrib><creatorcontrib>Haydar, Tarik F.</creatorcontrib><creatorcontrib>Sherman, Stephanie L.</creatorcontrib><creatorcontrib>Strydom, André</creatorcontrib><creatorcontrib>Bhattacharyya, Anita</creatorcontrib><title>Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society</title><title>Molecular syndromology</title><addtitle>Mol Syndromol</addtitle><description>Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and pharmacological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.</description><subject>Life Sciences</subject><subject>Syndrome Conferences, Symposia or Workshops</subject><issn>1661-8769</issn><issn>1661-8777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptkc-PEyEUx4nRuJt1D96NIfHiHqowwAAeTNbqupvUmNh68EQY5k0HnUKFmd30v3dq6_gjHgiE9-HzePki9JiSF5QK_ZIQIijnTN5Dp7Qs6UxJKe9P51KfoPOcv44YYbpQlD5EJ4zzgnKtT1F8M_iu9mGN-xbw1dAPCfCqhWS3HjJuYsJv413Ay12oU9zAq31xXD7V-Cb0kILtfQy2w_MYGkgQHODY_LStCoo_QQabXIuX0Xnod4_Qg8Z2Gc6P-xn6fPVuNb-eLT6-v5lfLmaOC9XPLKmYUpyVDqgrgJRFpUDXavxzxaGkUhLKRKXGWQGUbqwqJXdSKqeBF1qzM_T64N0O1QZqB6FPtjPb5Dc27Uy03vxdCb4163hrFGNaEDEKLg6C9p9n15cLs78jjAktC35LR_b5sVmK3wfIvdn47KDrbIA4ZFOIkkkqZMl-a12KOSdoJjclZp-nmfIc2ad_zjCRv9IbgWcH4JtNa0gT8GH55aAw27oZqSf_pY5dfgAWya6f</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Dierssen, Mara</creator><creator>Herault, Yann</creator><creator>Helguera, Pablo</creator><creator>Martínez de Lagran, Maria</creator><creator>Vazquez, Anna</creator><creator>Christian, Bradley</creator><creator>Carmona-Iragui, Maria</creator><creator>Wiseman, Frances</creator><creator>Mobley, William</creator><creator>Fisher, Elizabeth M.C.</creator><creator>Brault, Veronique</creator><creator>Esbensen, Anna</creator><creator>Jacola, Lisa M.</creator><creator>Potier, Marie Claude</creator><creator>Hamlett, Eric D.</creator><creator>Abbeduto, Leonard</creator><creator>del Hoyo Soriano, Laura</creator><creator>Busciglio, Jorge</creator><creator>Iulita, Maria Florencia</creator><creator>Crispino, John</creator><creator>Malinge, Sébastien</creator><creator>Barone, Eugenio</creator><creator>Perluigi, Marzia</creator><creator>Costanzo, Floriana</creator><creator>Delabar, Jean Maurice</creator><creator>Bartesaghi, Renata</creator><creator>Dekker, Alain D.</creator><creator>De Deyn, Peter</creator><creator>Fortea Ormaechea, Juan</creator><creator>Shaw, Patricia A.</creator><creator>Haydar, Tarik F.</creator><creator>Sherman, Stephanie L.</creator><creator>Strydom, André</creator><creator>Bhattacharyya, Anita</creator><general>Karger</general><general>S. Karger AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3360-4498</orcidid><orcidid>https://orcid.org/0000-0003-3062-7384</orcidid><orcidid>https://orcid.org/0000-0003-2462-7150</orcidid><orcidid>https://orcid.org/0000-0002-0360-7145</orcidid><orcidid>https://orcid.org/0000-0001-7049-6900</orcidid></search><sort><creationdate>20210701</creationdate><title>Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society</title><author>Dierssen, Mara ; Herault, Yann ; Helguera, Pablo ; Martínez de Lagran, Maria ; Vazquez, Anna ; Christian, Bradley ; Carmona-Iragui, Maria ; Wiseman, Frances ; Mobley, William ; Fisher, Elizabeth M.C. ; Brault, Veronique ; Esbensen, Anna ; Jacola, Lisa M. ; Potier, Marie Claude ; Hamlett, Eric D. ; Abbeduto, Leonard ; del Hoyo Soriano, Laura ; Busciglio, Jorge ; Iulita, Maria Florencia ; Crispino, John ; Malinge, Sébastien ; Barone, Eugenio ; Perluigi, Marzia ; Costanzo, Floriana ; Delabar, Jean Maurice ; Bartesaghi, Renata ; Dekker, Alain D. ; De Deyn, Peter ; Fortea Ormaechea, Juan ; Shaw, Patricia A. ; Haydar, Tarik F. ; Sherman, Stephanie L. ; Strydom, André ; Bhattacharyya, Anita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-a0b388436ce1c2e062b8e9d8499b4e61770135b8877ee89fa8674c778c9e42993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Life Sciences</topic><topic>Syndrome Conferences, Symposia or Workshops</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dierssen, Mara</creatorcontrib><creatorcontrib>Herault, Yann</creatorcontrib><creatorcontrib>Helguera, Pablo</creatorcontrib><creatorcontrib>Martínez de Lagran, Maria</creatorcontrib><creatorcontrib>Vazquez, Anna</creatorcontrib><creatorcontrib>Christian, Bradley</creatorcontrib><creatorcontrib>Carmona-Iragui, Maria</creatorcontrib><creatorcontrib>Wiseman, Frances</creatorcontrib><creatorcontrib>Mobley, William</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C.</creatorcontrib><creatorcontrib>Brault, Veronique</creatorcontrib><creatorcontrib>Esbensen, Anna</creatorcontrib><creatorcontrib>Jacola, Lisa M.</creatorcontrib><creatorcontrib>Potier, Marie Claude</creatorcontrib><creatorcontrib>Hamlett, Eric D.</creatorcontrib><creatorcontrib>Abbeduto, Leonard</creatorcontrib><creatorcontrib>del Hoyo Soriano, Laura</creatorcontrib><creatorcontrib>Busciglio, Jorge</creatorcontrib><creatorcontrib>Iulita, Maria Florencia</creatorcontrib><creatorcontrib>Crispino, John</creatorcontrib><creatorcontrib>Malinge, Sébastien</creatorcontrib><creatorcontrib>Barone, Eugenio</creatorcontrib><creatorcontrib>Perluigi, Marzia</creatorcontrib><creatorcontrib>Costanzo, Floriana</creatorcontrib><creatorcontrib>Delabar, Jean Maurice</creatorcontrib><creatorcontrib>Bartesaghi, Renata</creatorcontrib><creatorcontrib>Dekker, Alain D.</creatorcontrib><creatorcontrib>De Deyn, Peter</creatorcontrib><creatorcontrib>Fortea Ormaechea, Juan</creatorcontrib><creatorcontrib>Shaw, Patricia A.</creatorcontrib><creatorcontrib>Haydar, Tarik F.</creatorcontrib><creatorcontrib>Sherman, Stephanie L.</creatorcontrib><creatorcontrib>Strydom, André</creatorcontrib><creatorcontrib>Bhattacharyya, Anita</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular syndromology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dierssen, Mara</au><au>Herault, Yann</au><au>Helguera, Pablo</au><au>Martínez de Lagran, Maria</au><au>Vazquez, Anna</au><au>Christian, Bradley</au><au>Carmona-Iragui, Maria</au><au>Wiseman, Frances</au><au>Mobley, William</au><au>Fisher, Elizabeth M.C.</au><au>Brault, Veronique</au><au>Esbensen, Anna</au><au>Jacola, Lisa M.</au><au>Potier, Marie Claude</au><au>Hamlett, Eric D.</au><au>Abbeduto, Leonard</au><au>del Hoyo Soriano, Laura</au><au>Busciglio, Jorge</au><au>Iulita, Maria Florencia</au><au>Crispino, John</au><au>Malinge, Sébastien</au><au>Barone, Eugenio</au><au>Perluigi, Marzia</au><au>Costanzo, Floriana</au><au>Delabar, Jean Maurice</au><au>Bartesaghi, Renata</au><au>Dekker, Alain D.</au><au>De Deyn, Peter</au><au>Fortea Ormaechea, Juan</au><au>Shaw, Patricia A.</au><au>Haydar, Tarik F.</au><au>Sherman, Stephanie L.</au><au>Strydom, André</au><au>Bhattacharyya, Anita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society</atitle><jtitle>Molecular syndromology</jtitle><addtitle>Mol Syndromol</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>12</volume><issue>4</issue><spage>202</spage><epage>218</epage><pages>202-218</pages><issn>1661-8769</issn><eissn>1661-8777</eissn><abstract>Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and pharmacological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>34421499</pmid><doi>10.1159/000514437</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-3360-4498</orcidid><orcidid>https://orcid.org/0000-0003-3062-7384</orcidid><orcidid>https://orcid.org/0000-0003-2462-7150</orcidid><orcidid>https://orcid.org/0000-0002-0360-7145</orcidid><orcidid>https://orcid.org/0000-0001-7049-6900</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1661-8769 |
| ispartof | Molecular syndromology, 2021-07, Vol.12 (4), p.202-218 |
| issn | 1661-8769 1661-8777 |
| language | eng |
| recordid | cdi_crossref_primary_10_1159_000514437 |
| source | Karger Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Life Sciences Syndrome Conferences, Symposia or Workshops |
| title | Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T12%3A07%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Building%20the%20Future%20Therapies%20for%20Down%20Syndrome:%20The%20Third%20International%20Conference%20of%20the%20T21%20Research%20Society&rft.jtitle=Molecular%20syndromology&rft.au=Dierssen,%20Mara&rft.date=2021-07-01&rft.volume=12&rft.issue=4&rft.spage=202&rft.epage=218&rft.pages=202-218&rft.issn=1661-8769&rft.eissn=1661-8777&rft_id=info:doi/10.1159/000514437&rft_dat=%3Cproquest_cross%3E2563715763%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2563715763&rft_id=info:pmid/34421499&rfr_iscdi=true |